Replies to post #52241 on CBD Life Sciences Inc (CBDL)

[dtdude]

To me this isn’t about crazy potential in terms of revenue, but crazy potential in PPS in terms of how undervalued this will be if the revenue projections come to fruition, which seems very possible.

Given the fact they have very little debt, no dilution, clean balance sheet and upcoming revenue streams in a growing industry, the market cap right now is so low that the PPS could grow 10x and one could still argue its undervalued.

I don’t buy into crazy revenue projections, which is what most stinky pinkies offer. This one offers realistic revenue projections with a healthy balance sheet, which to me is golden given the current PPS.

[BRICK_TOP]

Where's Bravateck's revenue? All I see is operating loss, yet the "potential" is why the MC is $40 mil.
$OCSY MC is barely $3 mil and almost no debt. Bravateck debt is astounding at about $8 mil.